Position in NVS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$556,512
+$60,075 QoQ
Shares Held
3,551
+9.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#840
of 1,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 17%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pinnacle Bancorp, Inc. holds $17,238,730 across 16 Drug Manufacturers - General names. NVS ranks #5 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,700 | $6,836,751 | |
| 2 | JNJ |
Johnson & Johnson
|
16,748 | $4,253,489 | |
| 3 | ABBV |
AbbVie Inc.
|
12,680 | $3,190,795 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,566 | $1,229,231 | |
| 5 | NVS |
Novartis AG
This page
|
3,551 | $556,512 | |
| 6 | PFE |
Pfizer Inc
|
21,473 | $517,069 | |
| 7 | AMGN |
Amgen Inc
|
487 | $176,352 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,289 | $131,892 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $556,512 | 3,551 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $496,437 | 3,250 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $454,005 | 3,293 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $433,194 | 3,378 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $408,771 | 3,378 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $403,000 | 3,615 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $361,214 | 3,712 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $429,829 | 3,737 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $397,841 | 3,737 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $357,610 | 3,697 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $367,631 | 3,641 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $360,889 | 3,543 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $362,468 | 3,592 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $338,376 | 3,678 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $332,398 | 3,664 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $265,882 | 3,498 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $310,394 | 3,672 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $322,218 | 3,672 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $336,497 | 3,847 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $317,306 | 3,880 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $343,609 | 3,766 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $320,806 | 3,753 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $320,495 | 3,394 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $295,142 | 3,394 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $313,812 | 3,593 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $296,242 | 3,593 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||